EPIDEMIOLOGICAL AND CLINICAL FEATURES OF BACTERIAL PURULENT MENINGITIS IN CHILDREN OF MOSCOW
https://doi.org/10.22627/2072-8107-2018-17-1-5-11
Abstract
Data on etiology, epidemiology, clinical course and consequences of bacterial purulent meningitis in children of the city of Moscow are presented. The analysis of the dynamics of morbidity for the last 5 years is presented depending on etiology. In Moscow in recent years, there has been a change in serovars of meningococcus with an increase in W135, an increase in the proportion of pneumococcus and a decrease in the proportion of haemophilic type b. The modern aspects of the clinic, diagnosis, therapy and prevention of meningitis in children are considered.
About the Authors
L. N. Mazankova
Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation.
Russian Federation
Moscow.
Russian Federation
Moscow.
G. D. Guseva
Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation; National Research Center of pediatric hematology, oncology and immunology named after Dmitry Rogachev.
Russian Federation
Russian Federation
G. Guseva, Ph.D., infectious disease specialist, Department of Infectious Diseases.
Moscow.
I. A. Soldatova
Infectious Clinical Hospital №2 of the Moscow City Health Department.
Russian Federation
Russian Federation
I. Soldatova, head of the children's boxing department of the infectious clinical hospital №2.
Moscow.
References
1. Thigpen M.C., Whitney C.G., Messonnier N.E., et al. Bacterial meningitis in the United States, 1998—2007. N Engl J Med. 2011; 364:2016.
2. McIntyre P.B., O'Brien, K.L., Greenwood B., and van de Beek D. Effect of vaccines on bacterial meningitis worldwide. Lancet. 2012; 380: 1703—1711.
3. Meningococcal infection and purulent bacterial meningitis in the Russian Federation. Information-analytical review. Federal budgetary institution of science «Central Research Institute of Epidemiology» Rospotrebnadzor RF, 2016. (In Russ.)
4. State reports «On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2009, 2010, 2012, 2013, 2014, 2015, 2016» (In Russ.) http://www.rospotrebnadzor.ru/documents/
5. Kaplan S.L., Mason E.O. Jr, Wald E.R. et al. Decrease of invasive pneumococcal infection sin children among 8 children's hospital sin the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004; 113:443.
6. Netherlands Reference Laboratory for Bacterial Meningitis (AMC/ RIVM). Bacterial meningitis in the Netherlands annual report 2010. Amsterdam: University of Amsterdam; 2011.
7. Mironov K.O. Molecular-biological monitoring in epidemiological surveillance of purulent bacterial meningitis: Author's abstract of MD Thesis (Mеdicine)14.02.02. M., 2017. (In Russ.)
8. European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2016. All rights reserved, CMI, 22, S37—S62.
9. Brouwer M.C., McIntyre P., Prasad K., van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2013;6:CD004405.
10. Mazankova L.N., Nasr M.A., Guseva G.D., Kurchkova G.V., Parshina O.V., Guseva Т.S. Features of the production of cytokines in meningococcal infections in children. Detskiye Infektsii=Children's Infections. 2010; 9 (1): 17—22.(In Russ.)
11. Moiseenkova D.A. Diagnostic value of the level of procalcitonin in CSF in bacterial purulent meningitis in children: Author's abstract of PhD Thesis (Mеdicine)14.02.02. M., 2017. (In Russ.)
12. Skripchenko N.V., Sorokina M.N., Ivanova V.V. Bacterial meningitis in children. M.: Medicine, 2003: 314. (In Russ.)
13. Mayanskii N.A. et al. Sensitivity to antibiotics, clonal and serotypic variety of pneumococci in children with acute otitis media in Moscow. Clinical microbiology and antimicrobial chemotherapy. 2016; 18 (2): 84—92. (In Russ.)
14. Kalinogorskaya O.S., Belanov S.S., Volkova M.O. et al. Antibiotic resistance and serotype composition of Streptococcus pneumoniae isolated from children in St. Petersburg in 2010—2013. Antibiotics and Chemotherapy, 2015: 60; 1—2.(In Russ.)
15. Durando P., Faust Saul N., Torres A. Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria. Journal of Immunology Research, 2015, Article ID 934504, http:// dx.doi.org/10.1155/2015/934504
16. The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs): Data for decision-making around PCV use in childhood. International Vaccine Access Center (IVAC), John Hopkins University, Bloomberg School of Public Health, Jan 2017.
17. Bärnighausen T.T, Berkley S, Bhutta Z.A, Bishai D.M, Black M.M, Bloom D.E., et al. Reassessing the value of vaccines. The Lancet Global Health, May 2014; 2(5):e251–e252.
18. Hyde T.B, Dentz H, Wang S.A, Burchett H.E, Mounier-Jack S, Mantel C.F. The impact of new vaccine introduction on immunization and health systems: A review of the published literature. Vaccine. 2012 Oct 5; 30 (45): 6347—6358.
19. Order of the Ministry of Health №125n of March 21, 2014 «On the approval of the national calendar of preventive vaccinations and the vaccination calendar for epidemiological indications» (In Russ.)
20. Ministry of Defense of the Russian Federation Main military medical administration. «Meningococcal infection. Guidelines for prevention, diagnosis and treatment in the Russian armed forces»: methodical instructions . SPb.: VMA, 2010:160. (In Russ.)
Review
For citations:
Mazankova L.N., Guseva G.D., Soldatova I.A. EPIDEMIOLOGICAL AND CLINICAL FEATURES OF BACTERIAL PURULENT MENINGITIS IN CHILDREN OF MOSCOW. CHILDREN INFECTIONS. 2018;17(1):5-11. (In Russ.) https://doi.org/10.22627/2072-8107-2018-17-1-5-11
Views:
1049
Email this article 